TUCATINIB HEMI ETHANOLATE)
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | TUCATINIB HEMI ETHANOLATE) |
| DrugBank ID | DB11652 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 24 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| epithelioid sarcoma | TxGNN Knowledge Graph | L5 |
| sarcoma | TxGNN Knowledge Graph | L5 |
| streptococcal pneumonia | TxGNN Knowledge Graph | L5 |
| hepatitis c virus infection | TxGNN Knowledge Graph | L5 |
| chronic hepatitis c virus infection | TxGNN Knowledge Graph | L5 |
| aids | TxGNN Knowledge Graph | L5 |
| hiv infectious disease | TxGNN Knowledge Graph | L5 |
| lung cancer | TxGNN Knowledge Graph | L5 |
| non-small cell lung carcinoma (disease) | TxGNN Knowledge Graph | L5 |
| acute myeloblastic leukemia with maturation | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11